Acadian Asset Management
EVH icon

Acadian Asset Management’s Evolent Health EVH Stock Holding History

Acadian Asset Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4,341
Closed -$122K – 1792
2024
Q3 		$122K Buy
+4,341
New +$112K ﹤0.01% 1525
2022
Q4 		– Sell
-18,404
Closed -$660K – 1820
2022
Q3 		$660K Buy
+18,404
New +$648K ﹤0.01% 914
2020
Q3 		– Sell
-9,889
Closed -$70K – 2227
2020
Q2 		$70K Buy
+9,889
New +$66.2K ﹤0.01% 1814

Other funds holding EVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Acadian Asset Management's EVH Position: Q4 2024 in Review

Acadian Asset Management sold out of Evolent Health (EVH) in Q4 2024, closing a stake of 4,341 shares — an estimated $122K sold.

Acadian Asset Management first reported a position in EVH in Q2 2020 and held it in 3 quarters. The position peaked at $660K in Q3 2022. 240 funds tracked by Wall St. Rank hold EVH as of Q4 2024.

  • Acadian Asset Management reported no remaining Evolent Health position as of Q4 2024 after selling out during the quarter.
  • Acadian Asset Management sold 4,341 Evolent Health shares in Q4 2024, an estimated $122K.
  • Acadian Asset Management first reported a position in Evolent Health in Q2 2020 and held it in 3 quarters.
  • Acadian Asset Management's Evolent Health position peaked at $660K in Q3 2022.
  • 240 funds tracked by Wall St. Rank held Evolent Health as of Q4 2024.

Based on Acadian Asset Management's 13F filing for Q4 2024, filed 11 Feb 2025.